Ness Ziona, Oct. 14, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, announced today that all warrants previously held by the selling shareholder named in the Company’s July 2026 registration statement on Form F-1 (File No. 333-297602) (the “Form F-1”), which includes the warrants to purchase 6,785,715 ordinary shares registered for resale under that Form F-1, have been exercised  in full.  No investor holds any warrants or other rights to acquire shares from the Company, apart from an immaterial number of outstanding warrants issued to investment banks as part of prior fundraises.

As a result of the above, the Company maintains a clean and simplified capital structure with no ATM offering program, no convertible debt, and an immaterial number of outstanding warrants. Aside from an immaterial number of warrants, and standard equity awards and restricted share units granted under its employee incentive plans, the Company’s approximately 70 million ordinary shares outstanding represent nearly its entire fully diluted equity capitalization.

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for quantum computing and other advanced hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses potential conversion of equity awards and restricted share units into its ordinary shares. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485

QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485